Geode Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $299M | Buy |
|
|||||
|
2025
Q1 | $253M | Buy |
|
|||||
|
2024
Q4 | $187M | Buy |
|
|||||
|
2024
Q3 | $206M | Buy |
|
|||||
|
2024
Q2 | $180M | Buy |
|
|||||
|
2024
Q1 | $199M | Buy |
|
|||||
|
2023
Q4 | $179M | Buy |
|
|||||
|
2023
Q3 | $166M | Sell |
|
|||||
|
2023
Q2 | $189M | Buy |
|
|||||
|
2023
Q1 | $216M | Buy |
|
|||||
|
2022
Q4 | $230M | Buy |
|
|||||
|
2022
Q3 | $212M | Buy |
|
|||||
|
2022
Q2 | $212M | Buy |
|
|||||
|
2022
Q1 | $195M | Sell |
|
|||||
|
2021
Q4 | $211M | Buy |
|
|||||
|
2021
Q3 | $151M | Buy |
|
|||||
|
2021
Q2 | $81.2M | Buy |
|
|||||
|
2021
Q1 | $84.1M | Buy |
|
|||||
|
2020
Q4 | $62.6M | Buy |
|
|||||
|
2020
Q3 | $45.6M | Buy |
|
|||||
|
2020
Q2 | $40.3M | Buy |
|